not tagged
point biopharma
['$pnt', 'point bio']
$pnt(8.57) up 1.50 $pnt thin 1.50 point spike guggenheim analyst charles zhu raised the firm's price target on point biopharma to $22 from $20 and keeps a buy rating on the shares after the company presented full poster data at esmo 2022 with updated efficacy and safety data
Very varied...trading stocks, futures, options, fishing, hunting, cooking, wanting to make a difference. All posts are for entertainment purposes only.